{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-221696","form_type":"8-K","ticker":"SEER","cik":"0001726445","company_name":"Seer, Inc.","filed_at":"2026-05-13T20:19:36+00:00","discovered_at":"2026-05-13T20:21:00.286221+00:00","generated_at":"2026-05-13T21:52:18.975568+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Seer Q1 2026 revenue $2.8M (-34% YoY); reaffirms FY2026 guidance of $16M-$18M","bullets":["Revenue $2.8M, down 34% from $4.2M YoY, driven by depressed academic funding and competitive activity.","Net loss $16.8M vs $19.9M prior year; operating expenses down 20% to $18.2M.","Reaffirmed full year 2026 revenue guidance of $16M-$18M (3% growth at midpoint).","Ended Q1 with ~$220M cash and investments; repurchased ~1.5M shares in the quarter.","Appointed Anthony (Tony) Bazarko as CCO; secured collaboration with Precision Health Research, Singapore (10,000 samples)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-221696","json":"https://secwatch.observer/filing/0001193125-26-221696.json","markdown":"https://secwatch.observer/filing/0001193125-26-221696.md","text":"https://secwatch.observer/filing/0001193125-26-221696.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726445/000119312526221696/0001193125-26-221696-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726445/000119312526221696/ck0001726445-20260513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T21:52:18.975568+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}